RPE65 and retinitis pigmentosa 1: While the clinical presentation (e.g., age at onset, pattern, rate of progression), and hence, diagnostic labels (RP, LCA, early-onset retinal dystrophy (EORD), etc.)can vary between patients, the underlying disease caused by RPE65 mutations eventually leads to complete blindness if left untreated.